Brinter, Santa Monica, CA (2026)

11/11/2024

Joo, tehdään me Brinterissä
näitä avaruusjuttuja. Näitä kannattaa tehdä vaikkei heti löisi leiville!

Finland’s Brinter Technology AM has been selected to supply a 3D bioprinter to the International Space Station.

09/18/2023

Brinter presenting at BioFuture October 4-6, 2023 in NYC

https://www.brinter.com/biofuture

See CEO Tomi Alapaattikoski's presentation and meet us October 4-6 at Biofuture in New York, NY, where esteemed innovators and investors gather to assess and shape the future of healthcare.

If you are interested in learning more about Brinter’s ongoing investor round, our industry-changing cartilaginous bio-implants, enabled by our patented 3D biomanufacturing tech and our biosynthetic materials, please don’t hesitate to contact us. We will happily schedule a meeting with our Brinter Inc CEO Tom Alapaattikoski, at the conference or virtually.

“I am eager to be presenting this year at BioFuture in New York and meeting with the attending highly reputable LifeScience Investors.”

Tomi Alapaattikoski, CEO

You can learn more about the event here:�https://biofuture.com/about-the-event/

Brinter presenting at Biofuture October 4-6, 2023 in NYC See Brinter’s presentation and meet us October 4-6 at Biofuture in New York, NY, where esteemed innovators and investors gather to assess and shape the future of healthcare.If you are interested in learning more about Brinter’s ongoing inv...

08/11/2023

Brinter is attending: The 32nd BioCity Symposium: Sculpting Tissues – cells, matrix and forces

24–25 August 2023

Mauno Koivisto Centre, BioCity, Turku, FINLAND

https://www.brinter.com/biocity-symposium

Join us at the upcoming Symposium as we explore the mechanisms regulating tissue architecture and homeostasis in biological organisms. This complex and dynamic “sculpting” process is carefully coordinated from the very beginning of life. Cells build tissues by proliferating, migrating, altering phenotype, and generating a modifiable extracellular matrix (ECM). Brinter 3D bioprinter is a technology leader in this field, and re-creation of tissues with a 3D bioprinter is the key to studying and understand these processes better.

ECM’s biochemical and biomechanical properties determine cell behavior and cell-cell crosstalk, to control gene expression and cell state, and the response to injury and insult (tissue repair, fibrosis, inflammation, cancer) and therapeutic targeting. Brinter’s modular 3D bioprinter can handle and print all the different materials in the ECM-field.

You are very welcome to visit our booth at the symposium, to test our Brinter 3D bioprinter, and to talk more about your science.

https://biocityturku.fi/biocity-symposium/

Brinter is attending: The 32nd BioCity Symposium: Sculpting Tissues – cells, matrix and forces

07/27/2023

Brinter at Biotech CEO Summit – Strengthening Foundations for Growth

https://www.brinter.com/ceo-summit

Tomi Alapaattikoski, CEO and Co-founder of Brinter, a pioneering personalized bio-implant company, attended the private, invite-only Biotech CEO Summit in La Jolla, July 17-19, 2023.

With the theme “Strengthen Your Foundation, Prepare for Growth,” the invitational Biotech summit provided an ideal platform for industry’s top CEOs to define their company’s growth and financial strategies.

Brinter CEO Tom Alapaattikoski’s presence at the summit reaffirmed the company’s position as a key player in the biotech sector, receiving accolades for its exceptional innovation in the field. The company’s dedication to tissue therapeutics and personalized bio-implants garnered widespread praise, further fueling anticipation for their upcoming steps.

The Biotech CEO Summit served as a catalyst for Brinter to foster valuable connections with Biotech CEO’s and other industry peers, setting the stage for a promising future for the company.

Brinter at Biotech CEO Summit – Strengthening Foundations for Growth Brinter at Biotech CEO Summit – Strengthening Foundations for Growth Brinter, a pioneering personalized bio-implant company, attended the private, invite-only Biotech CEO Summit in La Jolla, July 17-19, 2023. With the theme “...

06/22/2023

Collaboration with SRM AP University in India

https://www.brinter.com/srm-ap

Brinter collaborates with SRM University AP in India, ushering in a new era of innovation and research in the faculty of Engineering and Sciences. Brinter’s state-of-the-art multi-material printer is capable of producing complex biological structures, such as tissues and organs, and other engineered materials with remarkable accuracy and precision. The partnership was in collaboration with 3D printer expert Sumant Bhutoria of Alfatek.

The collaboration allows researchers to create new models that closely mimic the structure and function of human organs or for example bioelectronics. This development could prove to be a game-changer in the field.

The Brinter ONE 3D Bioprinter is able to use a combination of materials, including cells to create 3D models of for example bioelectronic components or human tissues and organs. This allows researchers to test products, develop new materials, and study new structures with unprecedented precision. Brinter ONE’s ability to print complex structures with high accuracy and speed is also expected to reduce the cost of research and accelerate the development of new products.

It is expected that this will lead to new collaborations and partnerships between SRM and other Indian and international research institutions, and pave the way for more game changing discoveries in the future.

Brinter collaboration with SRM AP University in India Brinter collaborates with SRM University AP in India, ushering in a new era of innovation and research in the faculty of Engineering and Sciences. Brinter's state-of-the-art multi-material printer is capable

06/20/2023

PN Update: Brinter® 3D bioprinting advances meniscus implant knee repairs

Brinter® is developing 3D bioprinted personalized meniscus cartilage implants that promise to revolutionize knee surgery.

05/05/2023

PN Update: Brinter 3D bioprinter – Ease of use

Brinter® offers clear advantages in 3D bioprinting for the right price and is here to make 3D bioprinting mainstream in every lab and biomanufacturing plant in the world.

05/04/2023

Brinter Makes Waves at MedInvest Conference 2023

Key Takeaways from Brinter’s Presence in the MedTech Industry’s Premier Investor Event

https://www.brinter.com/medinvest-insights

The MedInvest Conference 2023 held in Palo Alto on March 28-29 brought together investors, industry professionals, and biotech enthusiasts to discuss the latest advancements in the medical technology sector. One of the most talked-about companies at the event was Brinter, a leader in 3D bioprinting technology, with its CEO Tomi Alapaattikoski in attendance. The conference proved to be an excellent platform for Brinter to showcase its pioneering work and to connect with potential investors.

The MedInvest Conference proved to be an excellent opportunity for Brinter to connect with potential investors. With its groundbreaking technology and promising applications, the company caught the eye of numerous venture capitalists and investment firms. These connections could lead to future funding rounds, enabling Brinter to continue its research and development efforts, as well as scale its operations.

The MedInvest Conference 2023 proved to be an invaluable platform for Brinter and its CEO Tom Alapaattikoski. The event not only showcased the company’s groundbreaking 3D bioprinting technology, but also fostered connections with potential investors and industry professionals. With the continued commitment to collaboration and innovation, Brinter is poised to be a driving force in the field of regenerative medicine and personalized healthcare.

Brinter Makes Waves at MedInvest Conference 2023

04/25/2023

Check out our newly published book chapter in Elsevier’s Handbook of Surgical Planning and 3D printing discussing how 3D bioprinting can be used for future treatment of osteoarthritis!

https://www.brinter.com/elseviers

This chapter was written by an amazing team of scientists and engineers during the EU Horizon 2020 program funded RESTORE project, including Sanna Turunen, Tomi Kalpio, Carl Lindahl, Chirag Jain Mysore Shanthinathan, Tahsin Akhter, Sebastian Concaro and Stina Simonsson.

We hope that this book chapter will inspire next-generation 3D bioprinted cartilage replacements to ensure that osteoarthritis remains in the past.

University of Gothenburg, Sahlgrenska University Hospital, 3dheals

Published Book Chapter in Elsevier’s Handbook of Surgical Planning: A Collaborative Effort Towards Using 3D Bioprinting for Future Treatment of Osteoarthritis

04/24/2023

PN Update: Brinter® joins influential Biotechnology Innovation Organizations

Pioneering clinical bio-implant and 3D bioprinting platform developer and manufacturer Brinter®, has strengthened its links to the North American market with membership of two influential organisations.

Brinter

11/11/2024

09/18/2023

08/11/2023

07/27/2023

06/22/2023

06/20/2023

05/05/2023

05/04/2023

04/25/2023

04/24/2023

Address

Website

Alerts

Contact The Business

Shortcuts

Share

Category